CLOSE
SITE MAP
イノベーションが
生まれる「まち」。

2021/08/27

Pitch 4-3 :Rege Nephro Co., Ltd. -Cell therapy for kidney diseases-

【Cell therapy for kidney diseases】

⇒The abstract is available in text.
Abstract of RegeNephro.pdf

Profile

Graduated from the Faculty of Law, Keio University. Assumed the representative director of Japan Vaccine (GSK and Daiichi Sankyo's JV) in June 2012 after working for Japan Roussel, Aventis Pharma, GSK as Corporate Planning Director, Managing Director, and CFO/Head of Business Development. He has experience in management and products & business development both in pharmaceutical and biotechnology companies.
He is currently an outside director of JCR Pharmaceuticals, Inc. and a corporate auditor of GSK Japan Group.